Cargando…
Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19: A Systematic Review, Meta-Analysis, and Trial Sequence Analysis
OBJECTIVE: This systematic review and meta-analysis aimed to find the association between serum Krebs von den Lungen-6 (KL-6) and the severity of Coronavirus disease 2019 (COVID-19) infection. DATA SOURCES: Databases of Embase, PubMed, Web of Science, Science Direct, and Google Scholar were searched...
Autores principales: | Shrestha, Abhigan Babu, Pokharel, Pashupati, Singh, Harendra, Shrestha, Sajina, Fioni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875321/ https://www.ncbi.nlm.nih.gov/pubmed/36710717 http://dx.doi.org/10.1177/11795484231152304 |
Ejemplares similares
-
Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients
por: Kurashige, Takashi, et al.
Publicado: (2020) -
Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis
por: Jiang, Dingyuan, et al.
Publicado: (2022) -
Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis
por: Shigemura, Masahiko, et al.
Publicado: (2012) -
Serum Krebs von den Lungen-6: Promising biomarker to differentiate CPFE from IPF
por: Demirdöğen, Ezgi, et al.
Publicado: (2022) -
Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019
por: Yamaya, Takafumi, et al.
Publicado: (2021)